PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: Effects of FAD mutations. Baki, L., Shioi, J., Wen, P., Shao, Z., Schwarzman, A., Gama-Sosa, M., Neve, R., & Robakis, N. EMBO Journal, 23(13):2586-2596, 2004. cited By 227![PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: Effects of FAD mutations [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Phosphatidylinositol 3-kinase (PI3K) promotes cell survival and communication by activating its downstream effector Akt kinase. Here we show that PS1, a protein involved in familial Alzheimer's disease (FAD), promotes cell survival by activating the PI3K/Akt cell survival signaling. This function of PS1 is unaffected by γ-secretase inhibitors. Pharmacological and genetic evidence indicates that PS1 acts upstream of Akt, at or before PI3K kinase. PS1 forms complexes with the p85 subunit of PI3K and promotes cadherin/PBK association. Furthermore, conditions that inhibit this association prevent the PS1-induced PI3K/Akt activation, indicating that PS1 stimulates PI3K/Akt signaling by promoting cadherin/PI3K association. By activating PI3K/Akt signaling, PS1 promotes phosphorylation/inactivation of glycogen synthase kinase-3 (GSK-3), suppresses GSK-3-dependent phosphorylation of tau at residues overphosphorylated in AD and prevents apoptosis of confluent cells. PS1 FAD mutations inhibit the PS1-dependent PI3K/Akt activation, thus promoting GSK-3 activity and tau overphosphorylation at AD-related residues. Our data raise the possibility that PS1 may prevent development of AD pathology by activating the PI3K/Akt signaling pathway. In contrast, FAD mutations may promote AD pathology by inhibiting this pathway.
@ARTICLE{Baki20042586,
author={Baki, L. and Shioi, J. and Wen, P. and Shao, Z. and Schwarzman, A. and Gama-Sosa, M. and Neve, R. and Robakis, N.K.},
title={PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: Effects of FAD mutations},
journal={EMBO Journal},
year={2004},
volume={23},
number={13},
pages={2586-2596},
doi={10.1038/sj.emboj.7600251},
note={cited By 227},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-3343005434&doi=10.1038%2fsj.emboj.7600251&partnerID=40&md5=2ddcc14539d32c1990a04bf3a6b5e9ad},
affiliation={Department of Psychiatry, Fishberg Res. Ctr. for Neurobiology, Mount Sinai School of Medicine, New York, NY, United States; Dept. of Psychiat. and Behav. Sci., State Univ. New York at Stony Brook, Stony Brook, NY, United States; Department of Psychiatry, McLean Hospital, Harvard University, Belmont, MA, United States; Mount Sinai School of Medicine, NYU, Annenberg Bldg., One Gustave Levy Pl., New York, NY 10029, United States},
abstract={Phosphatidylinositol 3-kinase (PI3K) promotes cell survival and communication by activating its downstream effector Akt kinase. Here we show that PS1, a protein involved in familial Alzheimer's disease (FAD), promotes cell survival by activating the PI3K/Akt cell survival signaling. This function of PS1 is unaffected by γ-secretase inhibitors. Pharmacological and genetic evidence indicates that PS1 acts upstream of Akt, at or before PI3K kinase. PS1 forms complexes with the p85 subunit of PI3K and promotes cadherin/PBK association. Furthermore, conditions that inhibit this association prevent the PS1-induced PI3K/Akt activation, indicating that PS1 stimulates PI3K/Akt signaling by promoting cadherin/PI3K association. By activating PI3K/Akt signaling, PS1 promotes phosphorylation/inactivation of glycogen synthase kinase-3 (GSK-3), suppresses GSK-3-dependent phosphorylation of tau at residues overphosphorylated in AD and prevents apoptosis of confluent cells. PS1 FAD mutations inhibit the PS1-dependent PI3K/Akt activation, thus promoting GSK-3 activity and tau overphosphorylation at AD-related residues. Our data raise the possibility that PS1 may prevent development of AD pathology by activating the PI3K/Akt signaling pathway. In contrast, FAD mutations may promote AD pathology by inhibiting this pathway.},
author_keywords={Alzheimer's disease; Cadherin; PBK; Presenilin; Tau},
correspondence_address1={Robakis, N.K.; Mount Sinai School of Medicine, NYU, Annenberg Bldg., One Gustave Levy Pl., New York, NY 10029, United States; email: nikos.robakis@mssm.edu},
issn={02614189},
coden={EMJOD},
pubmed_id={15192701},
language={English},
abbrev_source_title={EMBO J.},
document_type={Article},
source={Scopus},
}
Downloads: 0
{"_id":"5AMAE7oi6t6BGqKyy","bibbaseid":"baki-shioi-wen-shao-schwarzman-gamasosa-neve-robakis-ps1activatespi3kthusinhibitinggsk3activityandtauoverphosphorylationeffectsoffadmutations-2004","author_short":["Baki, L.","Shioi, J.","Wen, P.","Shao, Z.","Schwarzman, A.","Gama-Sosa, M.","Neve, R.","Robakis, N."],"bibdata":{"bibtype":"article","type":"article","author":[{"propositions":[],"lastnames":["Baki"],"firstnames":["L."],"suffixes":[]},{"propositions":[],"lastnames":["Shioi"],"firstnames":["J."],"suffixes":[]},{"propositions":[],"lastnames":["Wen"],"firstnames":["P."],"suffixes":[]},{"propositions":[],"lastnames":["Shao"],"firstnames":["Z."],"suffixes":[]},{"propositions":[],"lastnames":["Schwarzman"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Gama-Sosa"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Neve"],"firstnames":["R."],"suffixes":[]},{"propositions":[],"lastnames":["Robakis"],"firstnames":["N.K."],"suffixes":[]}],"title":"PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: Effects of FAD mutations","journal":"EMBO Journal","year":"2004","volume":"23","number":"13","pages":"2586-2596","doi":"10.1038/sj.emboj.7600251","note":"cited By 227","url":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-3343005434&doi=10.1038%2fsj.emboj.7600251&partnerID=40&md5=2ddcc14539d32c1990a04bf3a6b5e9ad","affiliation":"Department of Psychiatry, Fishberg Res. Ctr. for Neurobiology, Mount Sinai School of Medicine, New York, NY, United States; Dept. of Psychiat. and Behav. Sci., State Univ. New York at Stony Brook, Stony Brook, NY, United States; Department of Psychiatry, McLean Hospital, Harvard University, Belmont, MA, United States; Mount Sinai School of Medicine, NYU, Annenberg Bldg., One Gustave Levy Pl., New York, NY 10029, United States","abstract":"Phosphatidylinositol 3-kinase (PI3K) promotes cell survival and communication by activating its downstream effector Akt kinase. Here we show that PS1, a protein involved in familial Alzheimer's disease (FAD), promotes cell survival by activating the PI3K/Akt cell survival signaling. This function of PS1 is unaffected by γ-secretase inhibitors. Pharmacological and genetic evidence indicates that PS1 acts upstream of Akt, at or before PI3K kinase. PS1 forms complexes with the p85 subunit of PI3K and promotes cadherin/PBK association. Furthermore, conditions that inhibit this association prevent the PS1-induced PI3K/Akt activation, indicating that PS1 stimulates PI3K/Akt signaling by promoting cadherin/PI3K association. By activating PI3K/Akt signaling, PS1 promotes phosphorylation/inactivation of glycogen synthase kinase-3 (GSK-3), suppresses GSK-3-dependent phosphorylation of tau at residues overphosphorylated in AD and prevents apoptosis of confluent cells. PS1 FAD mutations inhibit the PS1-dependent PI3K/Akt activation, thus promoting GSK-3 activity and tau overphosphorylation at AD-related residues. Our data raise the possibility that PS1 may prevent development of AD pathology by activating the PI3K/Akt signaling pathway. In contrast, FAD mutations may promote AD pathology by inhibiting this pathway.","author_keywords":"Alzheimer's disease; Cadherin; PBK; Presenilin; Tau","correspondence_address1":"Robakis, N.K.; Mount Sinai School of Medicine, NYU, Annenberg Bldg., One Gustave Levy Pl., New York, NY 10029, United States; email: nikos.robakis@mssm.edu","issn":"02614189","coden":"EMJOD","pubmed_id":"15192701","language":"English","abbrev_source_title":"EMBO J.","document_type":"Article","source":"Scopus","bibtex":"@ARTICLE{Baki20042586,\r\nauthor={Baki, L. and Shioi, J. and Wen, P. and Shao, Z. and Schwarzman, A. and Gama-Sosa, M. and Neve, R. and Robakis, N.K.},\r\ntitle={PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: Effects of FAD mutations},\r\njournal={EMBO Journal},\r\nyear={2004},\r\nvolume={23},\r\nnumber={13},\r\npages={2586-2596},\r\ndoi={10.1038/sj.emboj.7600251},\r\nnote={cited By 227},\r\nurl={https://www.scopus.com/inward/record.uri?eid=2-s2.0-3343005434&doi=10.1038%2fsj.emboj.7600251&partnerID=40&md5=2ddcc14539d32c1990a04bf3a6b5e9ad},\r\naffiliation={Department of Psychiatry, Fishberg Res. Ctr. for Neurobiology, Mount Sinai School of Medicine, New York, NY, United States; Dept. of Psychiat. and Behav. Sci., State Univ. New York at Stony Brook, Stony Brook, NY, United States; Department of Psychiatry, McLean Hospital, Harvard University, Belmont, MA, United States; Mount Sinai School of Medicine, NYU, Annenberg Bldg., One Gustave Levy Pl., New York, NY 10029, United States},\r\nabstract={Phosphatidylinositol 3-kinase (PI3K) promotes cell survival and communication by activating its downstream effector Akt kinase. Here we show that PS1, a protein involved in familial Alzheimer's disease (FAD), promotes cell survival by activating the PI3K/Akt cell survival signaling. This function of PS1 is unaffected by γ-secretase inhibitors. Pharmacological and genetic evidence indicates that PS1 acts upstream of Akt, at or before PI3K kinase. PS1 forms complexes with the p85 subunit of PI3K and promotes cadherin/PBK association. Furthermore, conditions that inhibit this association prevent the PS1-induced PI3K/Akt activation, indicating that PS1 stimulates PI3K/Akt signaling by promoting cadherin/PI3K association. By activating PI3K/Akt signaling, PS1 promotes phosphorylation/inactivation of glycogen synthase kinase-3 (GSK-3), suppresses GSK-3-dependent phosphorylation of tau at residues overphosphorylated in AD and prevents apoptosis of confluent cells. PS1 FAD mutations inhibit the PS1-dependent PI3K/Akt activation, thus promoting GSK-3 activity and tau overphosphorylation at AD-related residues. Our data raise the possibility that PS1 may prevent development of AD pathology by activating the PI3K/Akt signaling pathway. In contrast, FAD mutations may promote AD pathology by inhibiting this pathway.},\r\nauthor_keywords={Alzheimer's disease; Cadherin; PBK; Presenilin; Tau},\r\ncorrespondence_address1={Robakis, N.K.; Mount Sinai School of Medicine, NYU, Annenberg Bldg., One Gustave Levy Pl., New York, NY 10029, United States; email: nikos.robakis@mssm.edu},\r\nissn={02614189},\r\ncoden={EMJOD},\r\npubmed_id={15192701},\r\nlanguage={English},\r\nabbrev_source_title={EMBO J.},\r\ndocument_type={Article},\r\nsource={Scopus},\r\n}\r\n\r\n","author_short":["Baki, L.","Shioi, J.","Wen, P.","Shao, Z.","Schwarzman, A.","Gama-Sosa, M.","Neve, R.","Robakis, N."],"key":"Baki20042586","id":"Baki20042586","bibbaseid":"baki-shioi-wen-shao-schwarzman-gamasosa-neve-robakis-ps1activatespi3kthusinhibitinggsk3activityandtauoverphosphorylationeffectsoffadmutations-2004","role":"author","urls":{"Paper":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-3343005434&doi=10.1038%2fsj.emboj.7600251&partnerID=40&md5=2ddcc14539d32c1990a04bf3a6b5e9ad"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bio.pnpi.nrcki.ru/wp-content/uploads/2019/12/lmgch_2019_10.txt","dataSources":["87fXC3NAxFNMB5YTH"],"keywords":[],"search_terms":["ps1","activates","pi3k","thus","inhibiting","gsk","activity","tau","overphosphorylation","effects","fad","mutations","baki","shioi","wen","shao","schwarzman","gama-sosa","neve","robakis"],"title":"PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: Effects of FAD mutations","year":2004}